Our website uses cookies. Cookies are small text files held on your computer. They allow us to give you the best browsing experience possible and help us to understand how you use our site. Some cookies have been set. You can block and delete cookies, but parts of our site won’t work without them. By using our website, you accept our use of cookies. Find out more about cookies here.

Find the HeartFlow Analysis at a location near you with our HeartFlow Finder tool!

close button

Thank You for Joining
HeartFlow in Denver

Connect with Us

More than before.

The HeartFlow® FFR CT Analysis non-invasively provides insight into the lesion-specific physiology of patients with suspected coronary artery disease.

Magnifying glass over document

Clinical Results

  • Greatly reduced unnecessary invasive testing compared to standard pathway 1
    • 61% of patients avoided an invasive angiogram
    • Similar rates of revascularization
    • Zero adverse clinical events among patients whose angiogram was canceled
  • Reduced cost of care by 26% compared to standard pathway 1
  • 200+ published clinical articles
Checkmark in badge

Acceptance

  • Reimbursed by the Centers for Medicare & Medicaid Services beginning January 1, 2018
  • Recommended by NICE in the UK for patients with stable recent onset chest pain
  • Determined by Blue Cross Blue Shield Association’s Evidence Street to provide a meaningful improvement in net health outcome
  • Covered by a growing number of major US commercial insurers, including Aetna, Anthem, and numerous other Blue Cross Blue Shield plans
  • Obtained Category III CPT codes from the American Medical Association
Globe

Reach

  • Chosen by physicians for 15,000+ patients
  • Utilized globally at 80+ medical institutions
  • Commercially available in the United States, Canada, Europe and Japan
Lines connecting dots to make a cube shape

Breakthrough Technology

  • Leverages deep learning and powerful computer algorithms to provide the HeartFlow Analysis within hours
  • Benefits from expanding data and experience

1 Douglas, et al. J Am Coll Cardiol 2016; 68:435-45.

Let's Connect at RSNA

* Required fields.

Up arrow